Company Directory - Liminatus Pharma, Inc
Company Details - Liminatus Pharma, Inc
Liminatus Pharma, Inc
Liminatus Pharma, Inc is a pharmaceutical company focused on the development of innovative treatments for various medical conditions. The company is actively involved in research and development to create effective therapies and improve patient outcomes.
CCI Score
CCI Score: Liminatus Pharma, Inc
40.00
Latest Event
Liminatus Pharma Regains Nasdaq Compliance
Liminatus Pharma, Inc experienced a significant share boost, surging 64% to $20.86 after announcing it had regained Nasdaq compliance. This development reflects the company’s renewed commitment to regulatory standards and corporate governance.
Take Action
So what can you do? Support by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
DISSENTER
Liminatus Pharma, Inc is currently rated as a Dissenter.
Latest Events
- JUN052025
Liminatus Pharma, Inc experienced a significant share boost, surging 64% to $20.86 after announcing it had regained Nasdaq compliance. This development reflects the company’s renewed commitment to regulatory standards and corporate governance.
Alternatives
Thousand Oaks, USA
13.45
The Woodlands, United States
-29.28
Indianapolis, United States
-34.93
Bagsværd, Denmark
18.59
Kenilworth, United States
12.60
Foster City, USA
1.62
Paris, France
0.39
Cambridge, United States
0.17
Pasadena, United States
0.00
China
0.00
Industries
- 325412
- Pharmaceutical Preparation Manufacturing
- 541714
- Research and Development in Biotechnology (except Nanobiotechnology)
- 541715
- Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)